Home Blood Testing Tasso focuses on at-home blood collection and testing services, signaling strong sales opportunities with clinical research organizations, pharmaceutical companies, and health systems seeking remote sampling capabilities for trials and population health programs.

Partnership Potential Active collaborations with ARUP, Neurogen Biomarking, SheMed, Thriva, and InnoVero demonstrate a mature partner network; leverage these relationships to approach adjacent players in clinical research, biomarker testing, anti-doping solutions, and brain-health ecosystems.

Doping & Events Participation in high-profile events like the Olympic Winter Games positions Tasso as a trusted provider for secure, painless sampling in competitive, high-visibility environments; explore sponsorship, deployment, and data-sharing opportunities with sports organizations and event organizers.

Clinical Research Expansion Recent news highlights a push to support clinical research with at-home testing; target contract research organizations, academic medical centers, and biopharma sponsors requiring scalable remote blood collection, enabling faster trial enrollment and diverse patient access.

Financing & Growth With substantial revenue and a strong funding base, there is room to propose integrated solutions combining hardware, software (HIPAA-compliant workflows), and services for end-to-end remote sampling, appealing to enterprise health systems and large diagnostics networks seeking efficiency gains.